New Data Showing Cannabis Markets Projected to Grow With a Compound Annual Rate Over 14%

Thursday, April 26, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+

PALM BEACH, Florida, April 26, 2018 /PRNewswire/ -- News Commentary 


to report issued by New Frontier Data, an authority in data, analytics and business intelligence in the cannabis industry, has refined their market projections for adult use and medical markets in an upcoming report, The U.S. Cannabis Report: 2018 Industry
Outlook. New Frontier is forecasting the legal cannabis market to grow to $25 billion by 2025 with a compound annual growth rate of 14.7%. Instrumental to the rise and growth in the pot-stock market caps is a steady shift in the way the public views the drug. Gone are the days where cannabis was considered too taboo for discussion. Instead, politicians regularly discuss their views on marijuana while on the campaign trail, and parents freely talk about cannabis with their children. Many feel it is a market that's expected to see continued robust sales growth in the coming months and years. Active companies today include: Body and Mind Inc. (CSE:BAMM) (OTC:BMMJ), CV Sciences, Inc. (OTCQB:CVSI), Cannabis Wheaton Income Corp. (TSX-V:CBW) (OTC:CBWTF), Isodiol International Inc. (CSE: ISOL) (OTC:ISOLF), Medical Marijuana, Inc. (OTC:MJNA).

Body and Mind Inc. (CSE:BAMM.CN) (OTC:BMMJ) BREAKING NEWS: Body and Mind Inc. is pleased to announce the Company has recently purchased high capacity weighing equipment which will be delivered and installed in approximately 90 days, which coincides with the expected completion date of the Company's current facility expansion.

BAM President Robert Hasman commented, "With increasing production, we must find more ways to automate our production line which is time consuming and labor intensive. The increased speed will help package products more quickly and efficiently, which is essential to reducing costs and maintaining excellent customer service. The multi head weight machine will accurately weigh and dispense flower products, including dispensing up to 20 packages per minute, a major increase over the manual process currently in place. We anticipate a relatively quick payback on this machinery and will look to add additional efficiency producing equipment in the coming months." Read this and more news for Body and Mind Inc. at:  

In other industry news and developments:

CV Sciences, Inc. (OTCQB:CVSI) recently announced that it will be exhibiting at the 15th Annual Nutrition and Health Conference, held on April 29th to May 2nd, 2018 at the Westin Boston Waterfront in Boston, MA as a Silver Level Sponsor. The Nutrition and Health Conference, produced by the Arizona Center for Integrative Medicine, is a continuing education conference that assembles internationally recognized researchers, clinicians, educators, and chefs whose work focuses on the interface between nutrition and healthful living. The conference will feature presentations and a lively panel discussion with renowned health expert Dr. Andrew Weil and nationally renowned nutrition experts discussing optimum diet and social and political issues related to food and nutrition. The Company operates two distinct business segments: a drug development division focused on developing and commercializing novel therapeutics utilizing synthetic CBD; and a consumer product division in manufacturing, marketing and selling plant-based CBD products to a range of market sectors.

Cannabis Wheaton Income Corp. (TSX-V:CBW.V) (OTCQB:CBWTF) announced this month that it has entered into a share purchase agreement with Robinson's Cannabis Incorporated ("Robinson's") to acquire all of the issued and outstanding shares of Robinson's. Located in Kentville, Nova Scotia, Robinson's is a privately-owned, late-stage licensed producer applicant under the Access to Cannabis for Medical Purposes Regulations (the "ACMPR") and is currently constructing a 27,700 square foot purpose-built cannabis cultivation facility. Robinson's has successfully completed Health Canada's paper-based review process and is currently in the "Confirmation of Readiness" ("COR") stage.

Isodiol International Inc. (CSE: ISOL.CN) (OTC:ISOLF), a global Bioactive CBD innovator specializing in the development of pharmaceutical and wellness products, and Level Brands Inc. (LEVB), an innovative marketing and licensing company that provides bold, unconventional, and socially responsible branding for leading businesses announced this week the launch of their newest jointly developed cannabidiol (CBD) products. The products are CBD pain-relieving cream, marketed under LEVB subsidiary Ireland Men One (I'M1); CBD oral sprays marketed under BeTr? | kathy irelandŪ Health & Wellness; and CBD edibles, marketed under Chef Andre Carthen Edibles. The new products will be available in early Summer 2018 at in-store and online retailers nationwide.

Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, this week announced that it has garnered news coverage in top U.S. consumer publication Men's Health. The April 20, 2018, article, "What You Need to Know About Using Cannabis for Workout Recovery," provides a high-level overview of what to expect when using cannabis-based recovery products for workouts. The article features the author's interview with Medical Marijuana, Inc. CEO Dr. Stuart Titus and his commentary on the use of cannabis and cannabidiol (CBD), dubbing him "Doctor Cannabis." It also highlights the Company's research and various investments in the biotech sector. DISCLAIMER: (MNU) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. MNU is NOT affiliated in any manner with any company mentioned herein. MNU and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. MNU's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material.  All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. MNU is not liable for any investment decisions by its readers or subscribers.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed MNU has been compensated forty nine hundred dollars for news coverage of the current press release issued by Body and Mind Inc. by a non-affiliated third party. MNU HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and MNU undertakes no obligation to update such statements.

Contact Information:  +1(561)325-8757


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store